Source: SiliconRepublic

Evonetix: Molten Ventures joins $54m funding round of biotech firm Evonetix

The Cambridge-based start-up is developing its own silicon chips to speed up the synthesis of DNA.Read more: Molten Ventures joins $54m funding round of biotech firm Evonetix

Read full article »

Evonetix's Competitors | Evonetix's News | Evonetix's Financials

Followers on Owler

Est. Annual Revenue

$5.0-25M

Est. Employees

25-100

CEO

Colin McCracken

CEO Approval Rating

90/100

Evonetix is an England-based synthetic biology company that develops and commercializes DNA synthesis for healthcare, pharmaceuticals and data storage markets.